Brain activity feedback during scans for people with fibromyalgia pain
Tests watching and steering brain activity to ease fibromyalgia pain in adults.
Key facts
- Who runs it
- Brigham and Women's Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Registry title
- Self-regulation of Real-time fMRI Brain Activity in Chronic Pain
- Status
- Recruiting
- People taking part
- 36 people, planned
- Started
- 31 Oct 2025
- Expected to end
- Feb 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cognitive Behavioral Therapy
- Disease Education
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with fibromyalgia who have ongoing pain. They will learn to steer their own brain activity during fMRI brain scans. They will also get 8 weekly sessions of either pain-focused talk therapy (CBT) or fibromyalgia education.
- Age
- 18 to 65 years
- Sex
- All sexes
- Disease stage
- Fibromyalgia by the Wolfe et al 2011 research criteria for at least one year. Average pain of at least 4/10, with pain on at least 50% of days.
- Earlier treatment
- Medicine doses must already be stable before joining. People must agree not to change medicines, doses or complementary (CAM) treatments during the trial.
Main reasons for not taking part
- Pregnant or breastfeeding
- Cannot have an MRI scan (for example implanted iron-containing metal), or anxiety or panic that gets in the way of scans
- Another chronic pain condition more painful than fibromyalgia, an acute pain condition, or a painful autoimmune or inflammatory disease
- History of psychosis, psychiatric hospital stay in the past 6 months, or active thoughts of suicide
- Routine or daily use of narcotics or substances of abuse
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Aged 18-65
- Meet the Wolfe et al 2011 research criteria for fibromyalgia for at least one year
- On stable doses of medication prior to entering the study and agree not to change medications or dosages (or CAM treatments) during the trial
- Baseline pain intensity of at least 4/10 on average and pain report for at least 50% of days
- Able to provide written consent and fluent in English
Who cannot take part
- Stimulant medications for the fatigue associated with sleep apnea or shift work (e.g., modafinil),
- Documented peripheral neuropathy of known cause (e.g diabetic neuropathy, chemotherapy-induced neuropathy, guillain-barre)
- Lower Limb Vascular Surgery or Current Lower Limb Vascular Dysfunction
- Comorbid acute pain condition
- Comorbid chronic pain condition that is rated by the subject as more painful than fibromyalgia
- Any psychiatric disorder involving a history of psychosis (e. g schizophrenia, severe personality disorders)
- History of anxiety disorders or significant anxiety symptoms interfering with fMRI procedures (e.g., panic)
- History of significant head injury (e.g., with substantial loss of consciousness)
- Psychiatric hospitalization in the past 6 months
- Autoimmune or inflammatory disease (RA, SLE, IBD) that causes pain
- Any impairment, activity or situation that in the judgment of the Study Coordinator or Principal Investigator that would prevent satisfactory completion of the study protocol. This includes unreliable, or inconsistent pain scores as deemed by the principal investigator
- Pregnant or nursing
- Contraindication to MRI (e.g., implanted ferrous metal)
- Other contraindications to MRI
- Participating in other therapeutic trials
- Active suicidal ideation
- Routine or daily use of narcotics or substances of abuse
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where in United States
- Athinoula A. Martinos Center for Biomedical ImagingBoston, United StatesContact: Soobin ChoiTaking people
About the trial
What the trial wants to find out
This study aims to explore the usefulness of self-regulation of brain activity in patients with fibromyalgia. Patients will use real-time functional magnetic resonance imaging (fMRI) neurofeedback to observe and regulate their own brain activity while applying mental strategies to reduce fibromyalgia pain. The study consists of 2 magnetic resonance imaging (MRI) visits that involve brain neuroimaging for fMRI neurofeedback tasks, as well as 8 weekly intervention sessions with a pain psychologist. Patients will be randomized to either Cognitive Behavioral Therapy (CBT) or Fibromyalgia Education groups.
The 2 groups in the trial
- Cognitive Behavioral TherapyTreatment being tested
8 individual weekly visits with a psychologist for pain-related CBT.
- Disease EducationExisting treatment, for comparison
8 individual weekly visits with a psychologist for fibromyalgia education (this is an active comparator arm, matched for provider contact).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Self-regulation of Real-time fMRI Brain Activity in Chronic Pain: A Potential Neurobiological Mechanism of Cognitive Behavioral Therapy
- Plain-language title
- Brain activity feedback during scans for people with fibromyalgia painGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT07023523, who can take part
- Record updated
- 5 October 2026